Megan Sniecinski
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Megan Sniecinski
The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $7,929,124 for Megan Sniecinski in fiscal 2021, including a base salary of $286,192. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement
Start not stated–2022-04-25
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Business Officer | $286,192 | $7,929,124 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Business Officer | $456,750 | $2,012,335 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Business Officer | $225,000 | $2,176,954 |
Recent activity
No call appearances or filed executive changes recorded yet.